SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001395064-22-000067
Filing Date
2022-05-09
Accepted
2022-05-09 06:08:09
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13D sc13d_050922.htm SC 13D 117902
2 EX-1 exhibit1_050922.htm EX-1 1979
3 EX-2 exhibit2_050922.htm EX-2 6948
4 EX-4 exhibit4_050922.htm EX-4 52545
  Complete submission text file 0001395064-22-000067.txt   180894
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93640 | Film No.: 22903120
SIC: 2836 Biological Products, (No Diagnostic Substances)